Study of Safety and Tolerability of VLX600, an Iron Chelator, in Patients With Refractory Advanced Solid Tumors
Clinical trial NCT02222363 · TERMINATED
Trial details
- NCT number
- NCT02222363
- Sponsor
- Vivolux AB
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-18
- Primary completion
- 2016-12-28
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.